MedTrace Logo

Gene Expression in Tumor Tissue From Women Undergoing Surgery for Breast Cancer or Core Biopsy of the Breast

NCT00898937 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 55

Last updated 2018-04-13

Study results available
· View outcomes & findings →

Summary

RATIONALE: Studying samples of breast tissue in the laboratory may help doctors learn more about the genes and proteins found in breast tissue.

PURPOSE: This phase I trial is studying genes and proteins in breast tissue from women undergoing surgery for breast cancer or core biopsy of the breast.

Conditions

Interventions

GENETIC

microarray analysis

tumor specimen will be assessed by microarray analysis

PROCEDURE

breast biopsy

A breast biopsy will be done to obtain a tumor specimen

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Georgetown University

    lead OTHER

Principal Investigators

  • Claudine Isaacs, MD · Lombardi Comprehensive Cancer Center

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-09-30
Primary Completion
2014-12-31
Completion
2017-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00898937 on ClinicalTrials.gov